Biocon
Amarnath Paluru is a seasoned professional in the field of Environmental Health and Safety (EHS) and sustainability, currently serving as Senior Director at Biocon since July 2023. Prior to this role, Amarnath held the position of Deputy General Manager at Aragen Life Sciences from November 2017 to July 2023. Educationally, Amarnath holds a Master's degree in Environmental Sciences from Andhra University, obtained from 2002 to 2004, and a Bachelor's degree in Biotechnology and Chemistry from the same institution, completed between 1999 and 2002. Additionally, Amarnath has earned a Diploma in Industrial Safety from the State Board of Technical Education and Training.
This person is not in any teams
This person is not in any offices
Biocon
22 followers
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company's brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.